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ABSTRACT
Background: B7-H2 is a ligand for the inducible costimulator (ICOS). The aim of this study was to examine
the expression and function of B7-H2 in human airway smooth muscle (ASM) cells and compare them with
those of CD40 or OX40 ligand (OX40L).
Methods: Expression of B7-H2, CD40 and OX40L in ASM cells and their respective counterparts in T cells
was analyzed by RT-PCR or flow cytometry. The modulating effect of polyinosinic-polycytidylic acid (poly I:C)
on expression of B7-H2, CD40 and OX40L was also examined. The function of these three molecules was
evaluated by virtue of adhesion of anti-CD3-activated T cells, IL-6 and IL-8 production and DNA synthesis.
Results: ASM cells constitutively expressed B7-H2, CD40 and OX40L that mediated adhesion of activated T
cells expressing ICOS, CD40L and OX40. ASM cells responded to poly I:C with upregulated expression of B7-
H2, CD40 and OX40L and displayed enhanced adhesion of activated T cells. Functional analysis performed on
untreated ASM cells showed that engagement of B7-H2 with ICOS-Ig clearly induced DNA synthesis, whereas
that of CD40 or OX40L with trimeric CD40L or OX40-Ig greatly increased IL-6 and IL-8 production. These re-
sponses were enhanced in poly I:C-treated ASM cells.
Conclusions: The data demonstrate that ASM cells express functionally active B7-H2, CD40 and OX40L and
suggest that B7-H2-dependent signaling may play an active role in a proliferative response rather than in cy-
tokine and chemokine production. In addition, the modulation of B7-H2, CD40 and OX40L expression and func-
tion by poly I:C may have important implications for the function of virus-infected ASM cells.
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INTRODUCTION
The airway inflammatory response that characterizes
the asthmatic phenotype involves the interaction of
structural cells, infiltrating cells, cytokines, chemoki-
nes and growth factors.1,2 Airway smooth muscle
(ASM) cells are a rich source of different inflamma-
tory mediators and play an important interactive role
with inflammatory and structural cells in the patho-
genesis of asthma.1,3,4 Many cytokines and growth
factors regulate the activity and proliferation of ASM
cells via autocrine and paracrine actions. ASM cell
proliferation is also inducible by contact with
mitogen-activated T cells.5 ASM cells express adhe-
sion molecules such as intercellular adhesion
molecule-1 and CD44 and costimulatory molecules
such as CD40 and OX40 ligand (OX40L).5-8 These ad-
hesion and costimulatory molecules interact with
their respective counterparts expressed on other cell
types. ASM cells also express several members of the
Toll-like receptor (TLR) family, including TLR3.9-12
Members of the family recognize pathogen-
associated molecular patterns and activate the innate
immune responses. In addition, ASM cells may have
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the capacity to act as antigen-presenting cells be-
cause they can express major histocompatibility com-
plex class II molecules.13 This potential capacity sug-
gests that ASM cells may participate in the adaptive
immune responses under certain conditions.
The B7 family, which is expressed by professional
antigen-presenting cells, including dendritic cells,
macrophages and B cells, forms another group of
costimulatory or coinhibitory molecules crucial for in-
teraction with antigen-primed T cells.14-16 The individ-
ual members of the family play important roles in
regulating T cell responses. For example, B7-1
(CD80) and B7-2 (CD86) are ligands for the costimu-
latory CD28 and coinhibitory cytotoxic T-lymphocyte
antigen-4. B7-H1 (CD274) and B7-DC (CD273) are
ligands for the programmed death-1 that delivers a
coinhibitory signal to T cells. B7-H2 (CD275) is a
ligand for the inducible costimulator (ICOS) that de-
livers a costimulatory signal to T cells in a fashion dif-
ferent from CD28. B7-H3 (CD276) enhances the in-
duction of cytotoxic T cells, although its receptor re-
mains to be identified. B7 homologs can signal into
the antigen-presenting cell on which they are ex-
pressed.17 Some of the B7 homologs are also demon-
strated on tissue cells such as nasal, bronchial and al-
veolar epithelial cells.18-21 With regard to B7-1 and
B7-2 expression on epithelial cells, however, conflict-
ing results are reported.18,22 Although there is a re-
port showing that ASM cells express low constitutive
levels of B7-1 and B7-2,23 little is known about the ex-
pression of B7 homologs by ASM cells.
In the present study, we analyzed the expression
profiles of B7-1, B7-2, B7-H1 and B7-H2 in primary
cultures of human ASM cells and describe the cell
surface expression of B7-H1 and B7-H2, but not of
B7-1 or B7-2. To explore the significance of the pres-
ence of B7-H2 on ASM cells, we examined the regula-
tion of B7-H2 expression by a synthetic ligand for
TLR3, the ability of B7-H2 to mediate adhesion of
anti-CD3 antibody-activated T cells and the functional
consequences of engagement of B7-H2 with ICOS-Ig,
a soluble chimeric protein, by measuring cytokine
and chemokine production and DNA synthesis. In ad-
dition, we compared the expression and function of
B7-H2 with those of CD40 or OX40L in ASM cells.
METHODS
CELLS
Primary cultures of normal human ASM cells from
five different donors were obtained from Clonetics
(San Diego, CA, USA). ASM cells were grown in
smooth muscle cell basal medium (Clonetics) con-
taining 5% fetal bovine serum, 1 ngml epidermal
growth factor, 2 ngml fibroblast growth factor, 10
μgml insulin, 50 μgml gentamycin and 50 ngml
amphotericin B, according to the manufacturer’s in-
structions. Confluent ASM cells from passages 3-5
were starved of serum and growth factors for 24
hours and used for all experiments. The airway epi-
thelial cell line BEAS-2B was obtained from American
Type Culture Collection (Rockville, MD, USA) and
maintained in Ham’s F12Dulbecco’s modified
Eagle’s medium (Life Technologies, Gaithersburg,
MD, USA) containing 10% fetal bovine serum, 2 mM
glutamine, 50 Uml penicillin and 50 μgml strepto-
mycin. Peripheral blood mononuclear cells (PBMC)
were separated by Ficoll-sodium metrizoate (Or-
ganon Teknica, Durham, NC, USA) density gradient
centrifugation from heparinized venous blood of
three different healthy adults who had given in-
formed consent to the blood donation. The study was
approved by the Ethics Committee of Sagamihara Na-
tional Hospital. T cells were negatively isolated from
PBMC by an indirect magnetic labeling system using
mouse monoclonal anti-human CD14, CD19, CD36
and CD56 antibodies (Dynal, Oslo, Norway), accord-
ing to the manufacturer’s instructions. Purified T
cells contained >98% CD3+ cells as determined by
flow cytometry and were suspended in RPMI1640
medium (Invitrogen, Grand Island, NY, USA) con-
taining 10% fetal bovine serum, 2 mM glutamine, 50
Uml penicillin and 50 μgml streptomycin.
REAGENTS
Recombinant human ICOS-Ig (homodimer), CD28-Ig
(homodimer) and trimeric CD40L were obtained
from R&D Systems (Minneapolis, MI, USA), and re-
combinant human OX40-Ig (homotrimer) was ob-
tained from Alexis (San Diego, CA, USA). Blocking
mouse monoclonal antibodies to human ICOS,
CD40L and OX40 were obtained from Ancell (Bay-
port, MI, USA). Culture plates uncoated or coated
with mouse monoclonal anti-human CD3 antibody
were obtained from BD Biosciences (Bedford, MA,
USA). Polyinosinic-polycytidylic acid (poly I:C), a syn-
thetic ligand for TLR3, was obtained from InvivoGen
(San Diego, CA, USA), and [3H]thymidine ([3H]TdR)
was obtained from Perkin Elmer Life Sciences (Bos-
ton, MA, USA). N-hydrosuccinimido-biotin was ob-
tained from Sigma-Aldrich (St. Louis, MO, USA). All
other chemicals were of analytical grade.
RT-PCR
Extraction of total cellular RNA and cDNA synthesis
by reverse transcriptase were performed as de-
scribed previously.12 The resultant cDNA was ampli-
fied on a thermal cycler using a Pyrobest DNA po-
lymerase kit (TaKaRa, Tokyo, Japan) by PCR using
the following sense and antisense primers: B7-1, 5’-T
GGTCTTTCTCACTTCTGTT-3’ and 5’-GGATCACAA
TGGAGAGGTTA-3’; B7-2, 5’-ATTCTCTTTGTGATG
GCCT-3’ and 5’-CCCTTGTCCTTGATCTGAA-3’; B7-
H1, 5’-ACTGGCATTTGCTGAACGCA-3’ and 5’-TACA
CCCCTGCATCCTGCAAT-3’; B7-H2, 5’-CGTGTACT
GGATCAATAAGACGG-3’ and 5’-TGAGCTCCGGTC
AAACGTGGCC-3’; the housekeeping gene glyceral-
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dehyde 3-phosphate dehydrogenase (GAPDH), 5’-TG
AAGGTCGGAGTCAACGGATTTGGT-3’ and 5’-CATC
TGGGCCATGAGGTCCACCAC-3’. The sequences of
these primer sets and the PCR conditions were the
same as described elsewhere.12,18,19,23 The amplified
products were subjected to electrophoresis on 2%
agarose gels and visualized by staining with ethidium
bromide. The detection of mRNA expression of B7-1,
B7-2, B7-H1 and B7-H2 in CD40L-stimulated PBMC
was confirmed by PCR amplification using primers
for these four B7 homologs (data not shown).
FLOW CYTOMETRY
The following mouse monoclonal antibodies were
used for flow cytometry: anti-human B7-1 and B7-2
(PharMingen, San Diego, CA, USA), anti-human B7-
H1 (eBioscience, San Diego, CA, USA), anti-human
B7-H2 (Lab Vision, Fremont, CA, USA), anti-human
OX40L (R&D Systems) and phycoerythrin-labeled
anti-human CD40, CD40L, OX40 and ICOS (Ancell).
IgG1 isotype control (MOPC21) was obtained from
Immunotech (Marseille, France), and IgG2b isotype
control was from R&D Systems. Anti-OX40L antibody
was biotinylated by the standard technique using N-
hydrosuccinimido-biotin. Cells (1 × 106ml) were in-
cubated in the presence of 1 mgml human IgG
(PharMingen) with the appropriate concentrations of
unlabeled or labeled antibodies for 1 hour at 4℃. B7-
1, B7-2, B7-H1 and B7-H2 expression was assessed by
staining with a fluorescein isothiocyanate-labeled sec-
ondary goat F(ab’)2 anti-mouse Ig (BioSource, Ca-
marillo, CA, USA), and OX40L expression was deter-
mined by staining with phycoerythrin-labeled strepta-
vidin (PharMingen). In each assay, isotype control
was used for negative staining. Samples were ana-
lyzed on a FACSCallibur using CellQuest software
(Becton Dickinson, San Jose, CA, USA). Expression
of immunoreactive proteins was expressed as a ratio
of the mean fluorescence intensity (MFI) obtained
with isotype control antibody, as described previ-
ously.12
QUANTITATIVE ADHESION ASSAY
This assay was performed according to some modifi-
cations of the procedure described elsewhere.5
Briefly, T cells purified from PBMC were activated
with immobilized anti-human CD3 antibody for 42
hours at 37℃ and pulsed with [3H]TdR (37 kBqml)
for the final 16-hour incubation. [3H]TdR-labeled acti-
vated T cells were pretreated with or without the indi-
cated blocking antibodies for 1 hour at 4℃, added to
ASM cells and allowed to adhere for 1 hour at 37℃.
After nonadherent cells were removed by washing,
adherent cells were recovered by using trypsin and
harvested onto glass fibre strips with a cell harvester.
Retained radioactivity was counted in a Wallac Mi-
croBeta Jet liquid scintillation counter (Perkin Elmer
Life Sciences) and expressed as the counts per min-
ute (cpm).
MEASUREMENT OF IL-6 AND IL-8
The concentrations of IL-6 and IL-8 in the culture su-
pernatants from ASM cells stimulated with or without
the indicated recombinant proteins for 24 hours at
37℃ were measured by commercially available
ELISA kits (BioSource), according to the manufac-
turer’s instructions.
DNA SYNTHESIS
DNA synthesis in ASM cells was measured by incor-
poration of [3H]TdR. Cells were stimulated with or
without the indicated recombinant proteins at 37℃
for 1 to 7 days, and [3H]TdR (37 kBqml) was added
for the final 12-hour incubation. After incubation, cells
were harvested, and [3H]TdR incorporation was
measured in a liquid scintillation counter. The stimu-
lation index was calculated as a ratio of the cpm re-
covered from stimulated cellsunstimulated cells.
STATISTICAL ANALYSIS
Data were expressed as means ± SEM. Statistical sig-
nificance of differences was determined with un-
paired or paired Student’s t test. Differences were
considered significant at p < 0.05.
RESULTS
ANALYSIS OF B7 HOMOLOG EXPRESSION IN
ASM CELLS AND BEAS-2B CELLS
We first examined whether human ASM cells consti-
tutively express B7 homologs, including B7-H2. RT-
PCR analysis showed that ASM cells were positive for
B7-1, B7-2, B7-H1 and B7-H2 mRNAs (Fig.1A, left
lane). Flow cytometric analysis showed that expres-
sion of B7-H1 and B7-H2, but not B7-1 or B7-2, was
detectable on ASM cells (Fig.1B, upper panels). Our
failure to detect B7-1 and B7-2 expression on ASM
cells was not caused by analytical errors, since the an-
tibodies used reacted with B7-1 and B7-2 expressed
on CD40L-stimulated PBMC (data not shown).
BEAS-2B cells, which were examined for comparison,
were positive for B7-1, B7-H1 and B7-H2 mRNAs and
negative for B7-2 mRNA (Fig.1A, right lane), and cell
surface expression of B7-H1 and B7-H2, but not B7-1
or B7-2, was detectable (Fig.1B, lower panels). The
observed expression profiles of mRNA and protein
for these four B7 homologs in BEAS-2B cells were in
keeping with previous reports.18,20,24 Flow cytometry
revealed that the expression level of B7-H1 and B7-H
2 was significantly higher in BEAS-2B cells than in
ASM cells (Fig. 1C). Our data demonstrated that B7-
H2, as well as B7-H1, was expressed on both ASM
cells and BEAS-2B cells.
EFFECT OF Poly I:C ON B7-H2, CD40 AND
OX40L EXPRESSION ON ASM CELLS
ASM cells are known to express low levels of CD40
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Fig. 1 Expression profiles of B7 homologs in ASM cels and BEAS-2B cels.  A: RT-PCR analysis of B7-1, B7-2, B7-H1 and 
B7-H2 mRNA expression in ASM cels from one representative donor and in BEAS-2B cels is shown. B: Flow cytometric analy-
sis of B7-1, B7-2, B7-H1 and B7-H2 expression on ASM cels from one representative donor and on BEAS-2B cels is shown. 
The doted tracing in each panel indicates background staining. C: The MFI for B7-1, B7-2, B7-H1 and B7-H2 expression was 
determined.  Results are presented as means ± SEM of five diferent donors (ASM cels) and three independent experiments 
(BEAS-2B cels). **p < 0.01.
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and OX40L.6,8 In addition, BEAS-2B cells are shown
to respond to poly I:C via TLR3 with increased B7 ho-
molog expression.24 Since ASM cells also express
TLR3,9-12 we next examined whether poly I:C can
modulate B7-H2, CD40 and OX40L expression on
ASM cells. Treatment of ASM cells with poly I:C (25
μgml) for 24 hours resulted in upregulated expres-
sion of these three molecules, as analyzed by flow cy-
tometry (Fig. 2A), and their upregulation was signifi-
cant (Fig. 2B). Under our experimental conditions,
however, B7-1 and B7-2 were undetectable on ASM
cells even after poly I:C treatment (data not shown).
INDUCTION OF ICOS, CD40L AND OX40 EX-
PRESSION ON T CELLS BY ANTI-CD3 ANTI-
BODY
To determine expression of counter molecules for
B7-H2, CD40 and OX40L by T cells, peripheral blood
T cells were activated with immobilized anti-CD3 anti-
body for 42 hours and analyzed for expression of
ICOS, CD40L and OX40 by flow cytometry. As ex-
pected, high expression of these three molecules was
induced on the surface of anti-CD3-activated T cells
(Fig. 3A). We observed that the induced expression
level of CD40L or OX40 was very high compared with
that of ICOS (Fig. 3B).
COSTIMULATORY MOLECULE-DEPENDENT
ADHESION OF T CELLS TO ASM CELLS
Based on the observations that B7-H2, CD40 and
OX40L were detected on ASM cells and upregulated
after poly I:C treatment and that ICOS, CD40L and
OX40 were expressed at high levels on anti-CD3-
activated T cells, we examined the capacity of T cells
to adhere to ASM cells. Microscopic examination
showed that compared with resting T cells (Fig. 4A),
a large number of anti-CD3-activated T cells adhered
to untreated ASM cells (Fig. 4B). Moreover, en-
hanced adhesion of anti-CD3-activated T cells to poly
I:C-treated ASM cells was observed (Fig. 4C). Since
Expression of B7-H2 in ASM Cells
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Fig. 2 Efect of poly I:C on B7-H2, CD40 and OX40L expression on ASM cels. A: ASM cels were treated with or without poly 
I:C (25 μg/ml) for 24 hours and analyzed for expression of B7-H2, CD40 and OX40L by flow cytometry.  The doted tracing in 
each panel indicates background staining.  Data from one representative donor are shown.  B: The MFI for B7-H2, CD40 and 
OX40L expression was determined. Results are presented as means ± SEM of five diferent donors. *p < 0.05, **p < 0.01.
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the results obtained demonstrated the active partici-
pation of activated T cells in their adhesion to ASM
cells, a quantitative adhesion assay was performed us-
ing [3H]TdR-labeled activated T cells. The participa-
tion of costimulatory molecules in T cell adhesion to
ASM cells was determined using blocking antibodies.
Preliminary experiments showed that pretreatment of
activated T cells with a mixture of anti-ICOS, anti-
CD40L and anti-OX40 antibodies markedly decreased
T cell adhesion to untreated ASM cells; retained ra-
dioactivities in the adherent T cells pretreated with
medium alone, control antibody (MOPC21) at 30 μg
ml and a combination of anti-ICOS, anti-CD40L and
anti-OX40 antibodies at 10 μgml were 4537 ± 1604,
4180 ± 1179 and 678 ± 152 cpm, respectively (means ±
SEM in three different experiments). In keeping with
microscopic examination, compared with untreated
ASM cells, poly I:C-treated ASM cells displayed ap-
proximately a two-fold increase in T cell binding (Fig.
5). We observed significant inhibition of binding to
both untreated and poly I:C-treated ASM cells when
activated T cells were pretreated with 10 μgml each
of anti-ICOS, anti-CD40L or anti-OX40 antibody. Al-
though inhibition by these three antibodies was in-
complete, no significant differences among them with
respect to blocking activity were seen, suggesting
that B7-H2, CD40 and OX40L on ASM cells contrib-
ute equally to adhesion of activated T cells express-
ing ICOS, CD40L and OX40.
IL-6 AND IL-8 PRODUCTION BY ASM CELLS
To examine the functional consequences of engage-
ment of B7-H2, CD40 and OX40L on ASM cell, we
evaluated cytokine and chemokine production by
measuring IL-6 and IL-8. To that end, ASM cells that
had been treated with or without poly I:C (25 μgml)
Kajiwara K et al.
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Fig. 3 Induction of ICOS, CD40L and OX40 expression on T cels by anti-CD3 antibody. A: T cels were cultured with or with-
out immobilized anti-CD3 antibody for 42 hours and analyzed for expression of ICOS, CD40L and OX40 by flow cytometry. The 
doted tracing in each panel indicates background staining.  Data from one representative donor are shown.  B: The MFI for 
ICOS, CD40L and OX40 expression was determined. Results are presented as means ± SEM of three diferent donors.
**p < 0.01, ***p < 0.001.
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for 24 hours were washed, rested for 12 hours and
then stimulated with or without 10 μgml each of
ICOS-Ig, CD40L or OX40-Ig for 24 hours. ICOS-Ig
had a tendency to increase IL-6 and IL-8 production
by untreated and poly I:C-treated cells, while CD40L
and OX40-Ig greatly increased IL-6 and IL-8 produc-
tion by both cells (Fig. 6). Although poly I:C-treated
cells produced much higher levels of IL-6 and IL-8
than untreated cells, this was due to poly I:C induc-
tion of IL-6 and IL-8 production, as reported previ-
ously.9,10 Compared with ICOS-Ig, CD40L and OX40-
Ig induced a two- to three-fold increase in IL-6 and IL-
8 production by untreated and poly I:C-treated cells.
Moreover, CD40L and OX40-Ig substantially en-
hanced IL-6 and IL-8 production by poly I:C-treated
cells. Consistent with the lack of surface expression
of B7-1 and B7-2, CD28-Ig (10 μgml) had no effect
on IL-6 and IL-8 production by untreated and poly I:C-
treated cells.
DNA SYNTHESIS IN ASM CELLS
We also explored whether ICOS-Ig, CD40L and
OX40-Ig have the ability to induce DNA synthesis in
ASM cells by measuring uptake of [3H]TdR. This
measurement was performed at 3, 5 and 7 days after
stimulation with or without 10 μgml each of ICOS-
Ig, CD40L or OX40-Ig, since 1-day stimulation by
these recombinant proteins did not promote DNA
synthesis in untreated and poly I:C-treated cells (data
not shown). As shown in Figure 7, ICOS-Ig could in-
duce DNA synthesis in untreated and poly I:C-treated
cells, reaching a peak at 5 days after stimulation and
declining thereafter. However, CD40L and OX40-Ig
had only minimal effects on DNA synthesis even after
5-day stimulation. Interestingly, poly I:C-treated cells
showed enhanced DNA synthesis in response to
ICOS-Ig, but not to CD40L or OX40-Ig. As expected,
CD28-Ig (10 μgml) did not induce DNA synthesis in
untreated and poly I:C-treated cells.
Expression of B7-H2 in ASM Cells
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Fig. 4 Adhesion of T cels to ASM cels. T cels were cultured with or without immobilized anti-CD3 an-
tibody for 42 hours. ASM cels were treated with or without poly I:C (25 μg/ml) for 24 hours. Resting (A) 
or anti-CD3-activated (B) T cels were added to untreated ASM cels.  Anti-CD3-activated T cels were 
added to poly I:C-treated ASM cels (C).  After incubation for 1 hour, nonadherent T cels were removed, 
and T cel adhesion to ASM cels was examined with a phase-contrast microscopy (×400).  Open and 
closed arows indicate T cels and ASM cels, respectively.  Results are representative of three experi-
ments using T cels from one donor and ASM cels from three diferent donors.
Fig. 5 Efect of blocking antibodies on adhesion of anti-CD3-activated T 
cels to ASM cels. [3H]TdR-labeled activated T cels were pretreated with 
10 μg/ml of control antibody (MOPC21) or with 10 μg/ml each of anti-ICOS, 
anti-CD40L or anti-OX40 antibody for 1 hour, added to ASM cels that had 
been treated with or without poly I:C (25 μg/ml) for 24 hours and alowed to 
adhere for 1 hour.  Retained radioactivity in adherent T cels was counted. 
Results are presented as means ± SEM of five experiments using T cels 
from one donor and ASM cels from five diferent donors. *p < 0.05, **p < 
0.01, ***p < 0.001.  Similar results were obtained when T cels from two 
other donors were used.
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DISCUSSION
This study showed that cultured human ASM cells
express costimulatory molecules capable of binding
anti-CD3-activated T cells. In addition to CD40 and
OX40L, B7-H2, as well as B7-H1, was also demon-
strated on ASM cells. B7-1 and B7-2, however, were
undetectable on ASM cells under our experimental
conditions. We observed that B7-H2, CD40 and
OX40L expression on ASM cells could be upregu-
lated by poly I:C and was accompanied by enhanced
adhesion of activated T cells where high expression
of ICOS, CD40L and OX40 was induced. Adhesion
was inhibited proportionally to the same extent by an-
tibodies directed against ICOS, CD40L and OX40 on
T cells, suggesting that B7-H2, CD40 and OX40L on
ASM cells contribute equally to T cell binding. Func-
tional analysis performed on ASM cells showed that
engagement of B7-H2 with ICOS-Ig clearly induced
DNA synthesis, whereas that of CD40 or OX40L with
CD40L or OX40-Ig greatly increased IL-6 and IL-8
production. Thus, B7-H2 on ASM cells appears to
play a role in a proliferative response rather than in
cytokine and chemokine production by binding ICOS
expressed on activated T cells.
B7-H2, which provides ICOS-dependent T cell
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Fig. 6 IL-6 and IL-8 production by ASM cels.  ASM cels were treated with or without poly I:C (25 
μg/ml) for 24 hours, washed, rested for 12 hours and then stimulated with or without 10 μg/ml each of 
ICOS-Ig, CD40L, OX40-Ig or CD28-Ig for 24 hours.  The concentrations of IL-6 and IL-8 in the super-
natants were quantified by ELISA procedures.  Results are presented as means ± SEM of five diferent 
donors. *p < 0.05, **p < 0.01.
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costimulation, is expressed on several types of profes-
sional antigen-presenting cells.15 Its expression is
also demonstrated on airway, alveolar and renal tubu-
lar epithelial cells.18-21,25 We found that B7-H2, as well
as B7-H1, was expressed on ASM cells, suggesting
their potential interaction with activated T cells ex-
pressing ICOS. The significance of the B7-H2ICOS-
mediated costimulation pathway in T cell activation is
well documented in various experimental sys-
tems.15,26-29 For example, blocking the B7-H2ICOS
interaction attenuates CD4+ T cell expansion and Th2
cytokine production, resulting in decreased Th2 re-
sponses. B7-1 and B7-2, which provide CD28-
dependent T cell costimulation, are expressed on acti-
vated B cells and other antigen-presenting cells.14-16
Despite a report that B7-1 and B7-2 are expressed at
low levels on ASM cells,23 we failed to detect surface
expression of B7-1 and B7-2. This result seems to be
in support of the previous finding that ASM cells ex-
pressing HLA-DR could not present alloantigen to
CD4+ T cells.13 We observed that the expression pro-
files of B7 homologs in ASM cells were quite similar
to those in BEAS-2B cells, an airway epithelial cell
line. Indeed, BEAS-2B cells also failed to express B7-
1 and B7-2 on their cell surface. This failure is consis-
tent with previous studies which showed that both
BEAS-2B cells and primary bronchial epithelial cells
lacked surface expression of B7-1 and B7-2.18,24 Our
data, showing that ASM cells express B7-H2, but not
B7-1 or B7-2, suggest that B7-H2 may provide a pri-
mary costimulatory signal on ASM cells.
ASM cells displayed upregulated expression of B7-
H2, as well as of CD40 or OX40L, following treatment
with poly I:C. It has been shown that TNF-α, a potent
pro-inflammatory cytokine, also upregulates CD40
and OX40L expression on ASM cells and B7-H2 ex-
pression on B cells, monocytes and A549 cells, a type
II alveolar epithelial cell line, whereas it downregu-
lates B7-H2 expression on dendritic cells, bronchial
epithelial cells and BEAS-2B cells.6,8,18,21,30 Therefore,
the modulating effect of TNF-α on B7-H2 expression
differs among cell types. Treatment of ASM cells with
poly I:C led to enhanced adhesion of anti-CD3-
activated T cells, suggesting that production of
double-stranded RNA by virus-infected ASM cells
may bring about a similar effect on T cell binding.
The observed adhesion was inhibited by pretreat-
ment of activated T cells with antibodies directed
against ICOS, CD40L and OX40. Since inhibition by
these antibodies was incomplete, additional adhesion
pathways might be involved with adhesion to ASM
cells. In this regard, mitogen-activated T cells have
been shown to adhere to ASM cells through integrins
and CD44.5 Although the contribution of such adhe-
sion molecules to adhesion of anti-CD3-activated T
cells to ASM cells was not examined in the present
study, intercellular adhesion molecule-1 expression
on ASM cells was also upregulated by poly I:C (data
not shown). This upregulation might be accompanied
by enhanced adhesion of anti-CD3-activated T cells.
Integrin receptors expressed on ASM cells have also
been shown to mediate eosinophil adhesion.31 In ad-
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Fig. 7 DNA synthesis in ASM cels.  ASM cels were treated with or without poly I:C (25 μg/ml) for 24 
hours, washed, rested for 12 hours and then stimulated with or without 10 μg/ml each of ICOS-Ig, 
CD40L, OX40-Ig or CD28-Ig for 3 to 7 days, and [3H]TdR was added for the final 12-hour incubation.  
DNA synthesis was measured by uptake of [3H]TdR. The basal values in untreated cels were 228 ± 69, 
270 ± 86 and 292 ± 71 cpm on days 3, 5 and 7, respectively, and those in poly I:C-treated cels were 375 
± 84, 398 ± 96 and 371 ± 98 cpm on days 3, 5 and 7, respectively (five experiments with diferent 
donors). The stimulation index was calculated as a ratio of the cpm recovered from recombinant protein-
stimulated cels/unstimulated cels. Results are presented as means ± SEM of five diferent donors. 
*p <0.05, **p < 0.01.
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dition, mast cell adhesion to ASM cells has recently
been shown to be mediated in part by tumor suppres-
sor in lung cancer-1, an Ig-like cell adhesion mole-
cule.32 Thus, at least three types of inflammatory cells
adhere to ASM cells through adhesion molecules.
Our observation of costimulatory molecule-dependent
adhesion of activated T cells to ASM cells, together
with the known fact that B7-H2, CD40 or OX40L on
antigen-presenting cells preferentially binds activated
rather than resting T cells,15,29,33,34 suggests the po-
tential for interaction of ASM cells with infiltrating T
cells in the inflamed airways through the B7-H2
ICOS, CD40CD40L or OX40LOX40 pathway.
Adhesion of inflammatory cells to ASM cells has
been shown to evoke many responses, including
DNA synthesis and cytokine and chemokine produc-
tion.5,23,31,35 For example, irradiated activated T cells
induce ASM cell DNA synthesis in a contact- depend-
ent manner, suggesting the possible involvement of
adhesion molecules andor costimulatory molecules.
In addressing the potential consequences of engage-
ment of B7-H2, CD40 and OX40L on ASM cells with
their respective counterparts expressed on anti-CD3-
activated T cells, our observations demonstrated that
direct activation of B7-H2 by ICOS-Ig evoked DNA
synthesis, whereas that of CD40 or OX40L by CD40L
or OX40-Ig induced high production of IL-6 and IL-8.
The latter finding is in line with previous studies
showing that the signal delivered by CD40 or OX40L
on ASM cells led to increased IL-6 production.6,7 Al-
though CD40L and OX40-Ig predominated over
ICOS-Ig in increasing IL-6 and IL-8 production, these
three recombinant proteins had no ability to induce
eotaxin production (data not shown). A recent study
has shown that mast cell adhesion to ASM cells can
induce eotaxin production.35 With regard to the func-
tion of upregulated B7-H2, CD40 and OX40L in poly I:
C-treated ASM cells, each of them was also function-
ally active. For example, engagement of upregulated
B7-H2 with ICOS-Ig led to enhanced DNA synthesis.
Although the mechanism involved in ICOS-Ig induc-
tion of DNA synthesis remains to be defined, ASM
cells have the capacity to produce growth factors
such as platelet-derived growth factor and insulin-like
growth factor.1,3 Given that prolonged exposure of
ASM cells to ICOS-Ig was required for the induction
of DNA synthesis, the possibility that this induction
might be dependent on autocrine production of
growth factor(s) cannot be ruled out. Since alterna-
tions in extracellular matrix proteins around the ASM
have been shown to modulate mitogenic stimulus-
induced DNA synthesis,36 the possibility that B7-H2
engagement might influence a profile of extracellular
matrix proteins cannot be also ruled out. Structural
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changes in ASM cells are important factors that con-
tribute to airway remodeling, a key feature of
asthma.37-39 Part of this remodeling includes induc-
tion of hypertrophy andor hyperplasia leading to in-
creased ASM mass that may alter airway function.
ASM cell proliferation that leads to hyperplasia has
been shown to be increased in asthmatic patients.40
The observation that poly I:C-treated ASM cells re-
sponded to ICOS-Ig with enhanced DNA synthesis
suggests a potential mechanism by which ICOS-
dependent adhesion of activated T cells to virus-
infected ASM cells induces an increase in prolifera-
tion. Consistent with the lack of B7-1 and B7-2 ex-
pression on ASM cells, CD28-Ig had no effect either
on DNA synthesis or cytokine and chemokine pro-
duction. Engagement of B7-1 and B7-2 on dendritic
cells with CD28-Ig, on the other hand, has been
shown to result in induction of IL-6 production.17
Taken together, our results demonstrate that B7-H2,
as well as CD40 or OX40L, can signal into ASM cells
and suggest that B7-H2-dependent signaling may play
an active role in ASM cell proliferation.
In summary, human ASM cells constitutively ex-
press B7-H2, CD40 and OX40L that mediate adhesion
of anti-CD3-activated T cells expressing ICOS, CD40L
and OX40. Although the ability of B7-H2 engagement
with ICOS-Ig to increase IL-6 and IL-8 production is
inferior to that of CD40 or OX40L engagement with
CD40L or OX40-Ig, B7-H2 engagement leads to in-
duction of DNA synthesis. In addition, treatment of
ASM cells with poly I:C upregulates expression of
functionally active B7-H2, CD40 and OX40L. This
upregulation may have important implications for the
function of virus-infected ASM cells. Our data sug-
gest that the possible B7-H2ICOS interaction be-
tween ASM cells and activated T cells may contribute
to ASM cell proliferation rather than to cytokine and
chemokine production.
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